+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Gastrointestinal Bleeding Treatment Market - Growth, Trends, and Forecasts (2020 - 2025)

  • ID: 4896264
  • Report
  • June 2020
  • Region: Global
  • 110 Pages
  • Mordor Intelligence


  • CONMED Corporation
  • Cook Group
  • ERBE Elektromedizin GmbH
  • Olympus Corporation
  • Ovesco Endoscopy AG
Gastrointestinal Bleeding refers to blood loss that occurs within the digestive organs. High prevalence of upper gastrointestinal bleeding, rise in applications of endoscopic hemostasis, and growing geriatric population are the main factors that are boosting the growth of the gastrointestinal bleeding treatment market. According to the World Health Organization (WHO), between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. The increase in the number of geriatrics leads to consequences, such as a greater incidence of life-threatening diseases which sometimes related to gastrointestinal bleeding, further requiring treatment from hospitals. This boost the growth of the studied market.

However, the dearth of skilled labor is expected to restrain the growth of the global market in the forecast period.

Key Market Trends

Upper GI Tract Segment is Expected to Register a Good Growth Over the Forecast Period

By GI tract division, the market has been segmented into Upper GI Tract, and Lower GI Tract. The upper GI tract accounted for major share in the gastrointestinal bleeding treatment market and this trend is likely to continue during the forecast period. A peptic ulcer is one of the most common causes of upper GI tract bleeding and is known to have increased prevalence owing to an increase in H. pylori infection. Irrespective of any region, the peptic ulcer cases are quite common because of unhealthy diet habits by many people. As per a recent article of 2019, published in Medscape, peptic ulcer disease affects approximately 4.6 million people annually in the United States with an estimated 10% of the US population having evidence of a duodenal ulcer at some time. Other conditions also include esophageal varices, gastritis, and cancer of the esophagus or stomach. In addition, the growing geriatric population and rise in applications of endoscopic hemostasis also contribute to the growth of the demand for treatments related to upper gastrointestinal bleedings.

North America is Expected to lead the Gastrointestinal Bleeding Treatment Market

North America leads the market owing to the upsurge in the demand for advanced treatment options, and the prevalence of upper gastrointestinal bleeding. According to The National Institute of Diabetes and Digestive and Kidney Diseases, every year, upper GI bleeding accounts for about 100,000 hospitalizations in the United States. There is a large section of the population in the adult age group across many states, which have unhealthy diet habits leading to several problems associated to the upper and lower gastrointestinal tract, which may lead to bleeding if not diagnosed properly. Thus, a growing burden of such patients are being observed approaching the hospitals for better treatment particularly during the advanced stage of the disease. This drives the market of the gastrointestinal bleeding treatment

Europe and the Asia Pacific are followed next after North America owing to the presence of a diversified patient pool, and emerging economies in these regions, thus driving this market.

Competitive Landscape

The major players in the gastrointestinal bleeding treatment market include Boston Scientific Corporation, CONMED Corporation, Cook Group, ERBE Elektromedizin GmbH, Olympus Corporation, Ovesco Endoscopy AG, STERIS PLC and US Medical Innovations are providing these products across the globe.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.
Note: Product cover images may vary from those shown


  • CONMED Corporation
  • Cook Group
  • ERBE Elektromedizin GmbH
  • Olympus Corporation
  • Ovesco Endoscopy AG

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of upper gastrointestinal bleeding
4.2.2 Technology Advancement Related to Gastrointestinal Diseases Treatment
4.3 Market Restraints
4.3.1 Dearth of Skilled Labor
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Product
5.1.1 Endoscopic Mechanical Devices
5.1.2 Endoscopic Thermal Devices
5.1.3 Others
5.2 By GI Tract Division
5.2.1 Upper GI Tract
5.2.2 Lower GI Tract
5.3 By End User
5.3.1 Hospitals/Clinics
5.3.2 Ambulatory Surgical Centres
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 CONMED Corporation
6.1.3 Cook Group
6.1.4 ERBE Elektromedizin GmbH
6.1.5 Olympus Corporation
6.1.6 Ovesco Endoscopy AG
6.1.8 US Medical Innovations
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group
  • ERBE Elektromedizin GmbH
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • US Medical Innovations
Note: Product cover images may vary from those shown